Chumakov, I., Milet, A., Cholet, N., Primas, G., Boucard, A., Pereira, Y., Graudens, E., Mandel, J., Laffaire, J., Foucquier, J., Glibert, F., Bertrand, V., Nave, K.-A., Sereda, M. W., Vial, E., Guedj, M., Hajj, R., Nabirotchkin, S., & Cohen, D. (2014). Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases, 9(1):. doi:10.1186/s13023-014-0201-x.